27.04.2011 • News • Sun Pharmaceutical Industries • Merck & Co. • generic drugs

Sun Pharma To Sell Some Merck Diabetes Drugs In India

Sun Pharmaceutical Industries has entered into a deal to market Merck & Co's diabetes drugs - sitagliptin and sitagliptin plus metformin  - in India, the two drugmakers said in a statement on Monday. Under the deal, Sun will have the rights to market the drugs only in India under different brand names, the firms said. Earlier in April, Sun and Merck formed a joint venture to develop and manufacture generic drugs for emerging markets.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature